Cell Cryopreservation Equipment Market To Reach $5.65 Billion By 2033

Cell Cryopreservation Equipment Market Growth & Trends

The global cell cryopreservation equipment market size is projected to reach USD 5.65 billion by 2033, growing at a CAGR of 11.08% during the forecast period, according to a new report by Grand View Research, Inc. The market is witnessing strong and accelerating growth, propelled by the increasing need for long-term, contamination-free storage of high-value biological samples across biopharmaceutical, clinical, and academic research settings. As cell-based therapies, regenerative medicine, and advanced biologics continue to gain prominence, the demand for reliable, precise, and scalable cryopreservation solutions is rising rapidly, driving innovation across equipment and consumable categories.

Advancements in cryopreservation equipment, including ultra-low temperature freezers, automated controlled-rate freezers, liquid nitrogen supply tanks, and high-performance incubators, are enhancing process consistency, sterility, and sample viability. These technologies support seamless integration into modern biobanking, R&D, and clinical manufacturing workflows. Features such as digital controls, remote monitoring, enhanced temperature uniformity, and energy-efficient cooling systems reduce risk, improve traceability, and optimize storage environments for sensitive cell materials.

In parallel, the consumables segment, comprising cryogenic vials, tubes, cooler boxes/containers, and other accessories, continues to evolve with advancements in materials science and sterile manufacturing. Single-use, pre-sterilized formats, stronger sealing mechanisms, and enhanced thermal stability ensure sample integrity throughout freezing, transportation, and long-term storage. These innovations minimize handling errors, enhance safety, and enable seamless compatibility with automated cryostorage systems.

The market’s growth is further supported by the expanding use of cryopreservation in personalized medicine, cell therapy manufacturing, IVF, vaccine development, and precision research applications. The increasing need for scalable, reproducible, and compliant storage solutions is transforming traditional cold-chain workflows, enabling faster processing, reduced variability, and improved sample recovery across clinical and commercial pipelines.

With rapid advancements in bioprocessing, cell-based therapeutics, and biobanking infrastructure, the cell cryopreservation equipment industry is positioned to play a critical role in ensuring the viability, safety, and scalability of next-generation therapies and research breakthroughs worldwide.

 Request a free sample copy or view report summary: Cell Cryopreservation Equipment Market Report

Cell Cryopreservation Equipment Market Report Highlights

• By product, the consumables/accessories segment dominated the market in 2024, due to their repeated usage across every freezing and storage cycle, driving continuous, high-volume demand. Their single-use, replacement-driven nature, especially for cryogenic vials, tubes, and storage containers, creates recurring revenue streams and makes them essential for maintaining sterility, sample integrity, and regulatory compliance in biobanking and cell therapy workflows.

• By application, stem cells accounted for the largest market share of 31.01% in 2024, due to their central role in regenerative medicine, cell therapy development, and advanced research programs. The increasing use of stem cells in clinical trials, biobanking, and personalized therapeutic applications drives substantial demand for reliable cryopreservation solutions. Their high value, sensitivity, and need for long-term, ultra-stable storage further amplify the requirement for specialized equipment and consumables, positioning stem cells as the dominant application category.

• The biopharmaceutical and pharmaceutical companies represented the largest end use segment with a share of 36.58% in 2024, as they rely heavily on cryopreservation for cell banking, biologics development, vaccine production, and advanced therapy manufacturing. Their extensive R&D activities, large-scale storage needs, and stringent quality and regulatory requirements drive high adoption of specialized cryopreservation equipment and consumables, making this segment the primary contributor to market demand.

• North America held the largest share of the market in 2024, due to its well-established biopharmaceutical industry, strong presence of leading cell therapy and biologics developers, and extensive biobanking infrastructure. High R&D investments, advanced technological adoption, and a supportive regulatory landscape further strengthen the region’s demand for reliable cryopreservation equipment and consumables.

• The Asia Pacific cell cryopreservation equipment industry is projected to grow at the fastest CAGR of 11.83% over the forecast period,

Cell Cryopreservation Equipment Market Segmentation

Grand View Research has segmented the global cell cryopreservation equipment market based on product, application, end use, and region:

Cell Cryopreservation Equipment Product Outlook (Revenue, USD Million, 2021 - 2033)

• Equipment

  • Freezers

  • Liquid Nitrogen Supply Tanks

  • Incubators

• Consumables/Accessories

  • Cryogenic vials

  • Cryogenic tubes

  • Cooler boxes/containers

  • Others

Cell Cryopreservation Equipment Application Outlook (Revenue, USD Million, 2021 - 2033)

• Stem Cells

• Reproductive Cells

• Bioproduction Cell Lines

• Primary Cells

• Others

Cell Cryopreservation Equipment End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Biopharmaceutical & Pharmaceutical Companies

• Academic and Research Institutes

• Biobanks

• IVF clinics

• Others

Cell Cryopreservation Equipment Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Cell Cryopreservation Equipment Market

• Thermo Fisher Scientific Inc.

• Azenta US Inc.

• MVE Biological Solutions.

• INOXCVA

• Haier Biomedical

• Kirsch GmbH

• Planer, a Hamilton Thorne company

• Eppendorf SE

• Labtron Equipment Ltd.